HomeMarketsIndicesDermTech (DMTK) CEO On Dermatology Genomics

DermTech (DMTK) CEO On Dermatology Genomics

DermTech (DMTK) is a dermatology genomics company that develops and markets novel non-invasive genomics tests. John Dobak, CEO of DermTech, discusses DMTK, as it is part of the NASDAQ Biotechnology Index (NBI). He talks about how DMTK has reached an agreement with BioIQ for its melanoma test to be included in health programs. He then goes over the outlook for DMTK. Tune in to find out more.

Trading 360

10 Jan 2022

ON AIR
2:00 am
Next Gen Investing
replay
12:00 am
Fast Market
REPLAY
1:00 am
Trading 360
REPLAY
ON AIR
2:00 am
Next Gen Investing
REPLAY
education
3:00 am
Your First Trade
REPLAY
3:30 am
Trading 360
REPLAY
4:30 am
Next Gen Investing
REPLAY
education
5:30 am
Your First Trade
REPLAY
6:00 am
Fast Market
REPLAY
7:00 am
Futures
8:00 am
Morning Trade Live
10:00 am
Trading 360
11:00 am
Fast Market
12:00 pm
Next Gen Investing
1:00 pm
The Watch List
2:00 pm
Market On Close
education
3:30 pm
Your First Trade
4:00 pm
Trading 360
REPLAY
5:00 pm
Fast Market
REPLAY
6:00 pm
Next Gen Investing
REPLAY
education
7:00 pm
Your First Trade
REPLAY
7:30 pm
Trading 360
REPLAY
8:30 pm
Fast Market
REPLAY
9:30 pm
Next Gen Investing
REPLAY
education
10:30 pm
Your First Trade
REPLAY
11:00 pm
Trading 360
REPLAY

Get Market Minute

Daily insights for every investor

FOLLOW US